Article Information
History
- April 10, 2024.
Article Versions
- Version 1 (March 17, 2023 - 13:18).
- Version 2 (September 27, 2023 - 11:19).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Qifang Bi1,⇞,
- Barbra A. Dickerman2,
- Huong Q. Nguyen3,
- Emily T. Martin4,
- Manjusha Gaglani5,6,
- Karen J. Wernli7,
- G.K. Balasubramani8,
- Brendan Flannery9,
- Marc Lipsitch*,2,
- Sarah Cobey*,1,
- the US Flu Vaccine Effectiveness Network Investigators**
- 1University of Chicago, Chicago, Illinois, USA
- 2Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- 3Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA
- 4University of Michigan School of Public Health, Ann Arbor, Michigan, USA
- 5Baylor Scott & White Health, Temple, Texas, USA
- 6Texas A&M University College of Medicine, Temple, Texas, USA
- 7Kaiser Permanente Bernard J. Tyson School of Medicine, Seattle, Washington, USA
- 8University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA
- 9National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
- ↵⇞Corresponding author; email: qifang.bi{at}gmail.com
↵* Equal contribution